Medtronic’s McGrath Mac portable video laryngoscope has been recalled due to the potential for the device to cause serious harm or death to the patient. This can occur due to the battery going past the set minimum power level, leading to increased temperatures and the possible explosion of the battery. Currently, only one injury has been reported. The FDA designated the recall as Class I, which is likely to hurt sales for the medical device giant in the laryngoscope market. The laryngoscope market value was $310.6m in 2023 and is projected to reach $508.2m in 2033, at a compound annual growth rate (CAGR) of 5.05%, according to GlobalData, a leading data and analytics company.

This is not the first recall for Medtronic’s laryngoscopes. In September 2023, the company issued a recall due to stolen, malfunctioning devices that were distributed by third parties. While no injuries were discovered about the issue, the company’s history of recalls could affect buyers. The seriousness of this latest recall can be expected to have a noticeable effect on Medtronic’s laryngoscope sales as hesitation to purchase these devices compared to competitors’ laryngoscopes sets in.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Medtronic currently holds approximately 10.3% of the laryngoscope market and is overshadowed by major competitors such as Ambu (13.4%), Karl Storz (15.1%), and Olympus (18.1%). With the ongoing Class I recall, the gap between Medtronic and these major players may widen. More specifically, in the submarket of portable video laryngoscopes, Medtronic and Karl Storz dominate the space with market shares of 39.9% and 30.6%, respectively. However, because of ongoing device malfunctions, Medtronic’s hold on this submarket may loosen to the benefit of Karl Storz.

GlobalData expects the overall laryngoscope market to experience stable growth going forward as the number of surgeries requiring airway management increases due to the growing prevalence of respiratory conditions requiring hospitalization.

While Medtronic remains a significant player in the laryngoscope market, incidences involving major damage to patients will have an impact on hospitals purchasing the company’s products, as they require absolute trust in the tools they use. As the demand for laryngoscopes continues to grow, Medtronic may experience a notable hit to its profits.

See Also:

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.